[¹⁸F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis

Eur Urol. 2018 Jan;73(1):145-146. doi: 10.1016/j.eururo.2017.09.024. Epub 2017 Oct 13.

Authors

Eugenia Accorsi Buttini¹, Federica Maritati¹, Augusto Vaglio²

Affiliations

¹ Nephrology Unit, University Hospital, Parma, Italy.
² Nephrology Unit, University Hospital, Parma, Italy. Electronic address: [email protected].

PMID: 29033102
DOI: 10.1016/j.eururo.2017.09.024

No abstract available

Publication types

Letter

MeSH terms

Fluorodeoxyglucose F18 / administration & dosage*
Humans
Immunosuppressive Agents / therapeutic use*
Positron-Emission Tomography*
Predictive Value of Tests
Radiopharmaceuticals / administration & dosage*
Remission Induction
Retroperitoneal Fibrosis / diagnostic imaging*
Retroperitoneal Fibrosis / drug therapy*
Retrospective Studies
Severity of Illness Index
Treatment Outcome

Substances

Immunosuppressive Agents
Radiopharmaceuticals
Fluorodeoxyglucose F18